72557-2
Rilpivirine [Susceptibility] by Phenotype method
Active
Part Description
LP135443-2 Rilpivirine
Rilpivirine (brand name Edurant) is a pharmaceutical drug, developed by Tibotec, for the treatment of HIV infection. It is a second-generation non-nucleoside reverse transcriptase inhibitor (NNRTI) with higher potency, longer half-life and reduced side-effect profile compared with older NNRTIs, such as efavirenz.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia,
http://en.wikipedia.org/wiki/Rilpivirine
LOINC Names Get Info
- Fully-Specified Name
- Rilpivirine:
Susc: Pt: Isolate: OrdQn: Phenotyping - Long Common Name
- Rilpivirine [Susceptibility] by Phenotype method
- Short Name
- Rilpivirine Islt Phenotyp
- Display Name
- Rilpivirine Phenotype method [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Rilpivirine
Part Model Get Info
- Component
- Rilpivirine
LP135443-2
- Analyte
- Rilpivirine
LP135443-2
- Component Numerator
- Rilpivirine
LP135443-2
- Component Numerator Core
- Rilpivirine
LP135443-2
- Component Numerator Core Suffix
- NULL
- Component Denominator
- NULL
- Component Denominator Core
- NULL
- Component Denominator Core Suffix
- NULL
- Challenge
- NULL
- Adjustment
- NULL
- Count
- NULL
- Property
- Susc
LP6870-2
- Time
- Pt
LP6960-1
- Time Core
- Pt
LP6960-1
- Time Modifier
- NULL
- System
- Isolate
LP7370-2
- System Core
- Isolate
LP7370-2
- Super System
- NULL
- Scale
- OrdQn
LP7752-1
- Method
- Phenotyping
LP28724-0
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.42
- Last Updated
- Version 2.73 (MIN)
- Order vs. Observation
- Both
- Common Test Rank Get Info
- 17396
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 49665-3 | HIV susceptibility panel by Phenotype method |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG41382-9 | RilpivirineSusc| |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| cs-CZ | Czech (Czechia) | Rilpivirin: |
| el-GR | Greek (Greece) | Ριλπιβιρίνη: Synonyms: ABXBACT OrdQn Pt Susc Απομονωμένο στέλεχος Ριλπιβιρίνη Φαινοτύπηση |
| es-ES | Spanish (Spain) | Rilpivirina: |
| es-MX | Spanish (Mexico) | Rilpivirina: |
| fr-CA | French (Canada) | Rilpivirine: |
| fr-FR | French (France) | Rilpivirine: |
| it-IT | Italian (Italy) | Rilpivirina: Synonyms: Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici Suscettibilità fenotipo virale |
| nl-NL | Dutch (Netherlands) | rilpivirine: |
| pl-PL | Polish (Poland) | Rylpiwiryna: Synonyms: wrażliwość (mikroorganizmów) |
| tr-TR | Turkish (Turkey) | Rilpivirin: |
| zh-CN | Chinese (China) | 利匹韦林: Synonyms: 4-[4-[4-[(E)-2-Cyanovinyl]-2,6-dimethylphenylamino]pyrimidin-2-ylamino]benzonitrile; |
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
LOINC Copyright
Copyright © Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://